These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3486732)

  • 1. Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.
    Saxena S; Nouri-Aria KT; Anderson MG; Eddleston AL; Williams R
    Clin Exp Immunol; 1986 Mar; 63(3):541-8. PubMed ID: 3486732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
    Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis].
    Müller C; Zielinski CC
    Acta Med Austriaca; 1987; 14(5):115-8. PubMed ID: 3125713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases.
    De Fernandez MA; Clark A; Triger DR
    Clin Exp Immunol; 1987 Mar; 67(3):655-61. PubMed ID: 3608234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 1 alpha production by peripheral blood monocytes from patients with chronic liver disease and effect of sera on interleukin 1 alpha production.
    Kakumu S; Tahara H; Fuji A; Yoshioka K
    J Clin Lab Immunol; 1988 Jul; 26(3):113-9. PubMed ID: 3148031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum interleukin 6 levels in patients with chronic hepatitis B.
    Kakumu S; Shinagawa T; Ishikawa T; Yoshioka K; Wakita T; Ito Y; Takayanagi M; Ida N
    Am J Gastroenterol; 1991 Dec; 86(12):1804-8. PubMed ID: 1962626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of interleukin-12-induced interferon-y production in vitro by peripheral blood mononuclear cells in patients with chronic liver disease.
    Imanishi H; Cheng J; Ikeda N; Saito M; Ohno M; Hara N; Shimomura S; Yamamoto T; Amuro Y; Fujiwara H; Hada T
    Hepatogastroenterology; 2003; 50(53):1502-5. PubMed ID: 14571773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro alpha-interferon treatment of peripheral blood mononuclear cells improves interleukin-2 activity in HBV-related chronic liver disease.
    Saxena S; Nouri-Aria KT; Anderson MG; Williams R; Eddleston AL
    J Hepatol; 1985; 1(4):385-93. PubMed ID: 3877114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
    Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
    Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative in vitro studies of cell-mediated immunity in chronic liver diseases].
    Königstedt B; Zipprich R; Nilius R
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):113-21. PubMed ID: 3487441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte responsiveness per unit volume of blood in patients with chronic nonalcoholic and alcoholic liver disease. Plasma inhibitory factors and functional defects of responder cells.
    Behrens U; Friedrich I; Vernace S; Schaffner F; Paronetto F
    J Clin Lab Immunol; 1982 Sep; 8(3):143-52. PubMed ID: 6982341
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.
    Fernandez-Cruz E; Escartin P; Bootello A; Kreisler M; Segovia de Arana JM
    Clin Exp Immunol; 1978 Mar; 31(3):436-42. PubMed ID: 657588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B.
    Leifeld L; Cheng S; Ramakers J; Dumoulin FL; Trautwein C; Sauerbruch T; Spengler U
    Hepatology; 2002 Oct; 36(4 Pt 1):1001-8. PubMed ID: 12297850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
    Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
    J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.
    Yoshioka K; Kakumu S; Murakami H; Fukui K
    Clin Exp Immunol; 1984 Jun; 56(3):669-76. PubMed ID: 6235072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease.
    Schäfer C; Schips I; Landig J; Bode JC; Bode C
    Z Gastroenterol; 1995 Sep; 33(9):503-8. PubMed ID: 8525652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
    Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
    Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon production by peripheral blood cells of patients with alcoholic liver disease (ALD).
    Daniluk J; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):231-8. PubMed ID: 7487359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity.
    Niigaki M; Fukuda R; Hamamoto S; Ishimura N; Ishihara S; Akagi S; Watanabe M; Kinoshita Y
    Am J Gastroenterol; 2000 Jan; 95(1):239-47. PubMed ID: 10638591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.